US › Healthcare

DaVita HealthCare Partners Inc (DVA)

US · Healthcare · Medical Care Facilities

$227.99-2.43%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$3.42B
Revenue YoY
+6.0%
Net profit
$197.5M
Profit YoY
+21.2%
EPS
$2.87
EPS estimate
$2.33
Net margin
5.8%

EPS came in at 2.87 against a street estimate of 2.33 — a beat of 23.2%.

Key statistics

Market cap
$15.41B
P/E
23.2
Forward P/E
16.6
P/B
21.63
Book value
$-11.41
EPS (TTM)
$10.37
52-week high
$244.49
52-week low
$101.00
50-day MA
$216.86
200-day MA
$156.65
Beta
0.88

Analyst view

Analysts rate DaVita HealthCare Partners Inc a hold (1 buy, 8 hold, 1 sell out of 10) with an average price target of $208.57.

Shareholding

Insiders
46.90%
Institutions
52.97%

Largest institutional holders

FundStake
Berkshire Hathaway Inc46.90%
Vanguard Group Inc6.47%
BlackRock Inc4.31%
Vanguard Capital Management, LLC3.40%
Morgan Stanley - Brokerage Accounts2.60%
Vanguard Portfolio Management, LLC2.31%
Amvescap Plc.2.29%
State Street Corp2.11%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for DaVita HealthCare Partners Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.